|
1. |
Regional Node Failure in Patients With Four or More Positive Lymph Nodes Submitted to Conservative Surgery Followed by Radiotherapy to the Breast |
|
American Journal of Clinical Oncology: Cancer Clinical Trials,
Volume 23,
Issue 3,
2000,
Page 217-221
Cynthia Aristei,
Anna Marsella,
Fausto Chionne,
Bianca Panizza,
Luigi Marafioti,
Anna Mosconi,
Roberta Cherubini,
Mariantonietta Colozza,
Preview
|
|
摘要:
A retrospective analysis was conducted to evaluate the incidence of nodal failure in a subgroup of patients who had T1-T2 breast cancer and four or more positive nodes. Sixty-four 5 patients ranging in age from 29 to 73 years (median, 51) received conservative surgery followed by radiotherapy to the breast between November 1980 and May 1995. Adjuvant chemotherapy was administered to 56 patients, 27 of whom were also treated with tamoxifen, which was used alone in 5 patients. Three patients received no adjuvant treatment. Sixty-two patients are evaluable for regional node failure. There were 10 nodal failures, 4 in the axillary and 6 in the supraclavicular regions, in 9 patients, at a median of 56.5 and 27 months, respectively. There was no internal mammary node failure. Median follow-up was 72.6 months. The 10-year probability of developing axillary and supraclavicular failure is 13.9 ± 7.7% and 10.5 ± 4.1%, respectively. Prognosis was better for patients with axillary and breast recurrence and worse when relapse was in the supraclavicular region. On the basis of our results and data already published in premenopausal patients, we believe that radiotherapy to the supraclavicular region should be considered in patients with four or more positive axillary nodes, after a complete dissection.
ISSN:0277-3732
出版商:OVID
年代:2000
数据来源: OVID
|
2. |
Low Grade Gliomas Treated With Adjuvant Radiation Therapy in the Modern Imaging Era |
|
American Journal of Clinical Oncology: Cancer Clinical Trials,
Volume 23,
Issue 3,
2000,
Page 222-226
David Mansur,
Javad Hekmatpanah,
Robert Wollman,
Loch Macdonald,
Kelly Nicholas,
Enrique Beckmann,
Arno Mundt,
Preview
|
|
摘要:
The purpose of this study is to evaluate tumor control and failure patterns in patients with low grade gliomas treated with surgery and conventional adjuvant radiation therapy. Twenty-eight patients with low grade gliomas (7 grade I, 21 grade II) were retrospectively evaluated. Extent of resection was gross total (3), subtotal (17), and biopsy alone (8). All grade I tumors underwent subtotal resection. Median radiation therapy dose was 54 Gy delivered to localized fields. Tumor control and patterns of failure were determined from follow-up computed tomography and/or magnetic resonance scans. Median follow-up was 86 months (range, 2.4–177 months). Thirteen patients (46%) (four grade I, nine grade II) developed tumor progression. The 5-year actuarial progression-free survival rates for grade I and grade II patients were 86% and 51%, respectively. Corresponding 5-year actuarial survival rates were 100% and 70%. All recurrences were within the treated volume. Our results reveal that conventional adjuvant radiation therapy is associated with high rates of local tumor progression in both grade II and incompletely resected grade I low grade gliomas. Alternative strategies need to be explored in these patients in an effort to improve tumor control and outcome.
ISSN:0277-3732
出版商:OVID
年代:2000
数据来源: OVID
|
3. |
Recurrent Malignant Chondroid Syringoma of the FootA Case Report and Review of the Literature |
|
American Journal of Clinical Oncology: Cancer Clinical Trials,
Volume 23,
Issue 3,
2000,
Page 227-232
Michael Barnett,
Marc Wallack,
Alejandro Zuretti,
Lilia Mesia,
Richard Emery,
Anthony Berson,
Preview
|
|
摘要:
Malignant chondroid syringoma, or mixed tumor of the skin, salivary gland type, is an uncommon neoplasm believed to originate in sweat glands. This neoplasm occurs mostly in women and is typically seen in the extremities and torso. A case of recurrent malignant chondroid syringoma of the right foot in a man aged 34 years is described with a review of pertinent literature. The surgically excised neoplasm was evaluated by routine histology, immunohistochemistry, and transmission electron microscopy. The malignant chondroid syringoma showed microscopic dermal satellite tumor nodules. Immunohistochemical staining was positive for keratin and S100 and negative for actin and p53. Ki-67 showed <10% positive staining. Ultrastructurally, the neoplasm was composed of epithelial cells with tonofilaments, cell junctions, and electron-dense amorphous keratin-like substance in the intercellular spaces. No evidence of myoepithelial differentiation was noted. Given the tumoral size, acral location, and histologic findings, the neoplasm was classified as a malignant chondroid syringoma. After reviewing the literature, it became apparent that wide surgical excision, adjuvant radiation therapy as well as patient education are critical in facilitating long-term survival.
ISSN:0277-3732
出版商:OVID
年代:2000
数据来源: OVID
|
4. |
Induction Chemotherapy Followed by Concurrent Chemotherapy and High-Dose Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Upper-thoracic and Midthoracic Esophagus |
|
American Journal of Clinical Oncology: Cancer Clinical Trials,
Volume 23,
Issue 3,
2000,
Page 233-238
Martin Stuschke,
Michael Stahl,
Hansjochen Wilke,
Martin Walz,
Anneruth Oldenburg,
Georg Stüben,
Siegfried Seeber,
Horst Sack,
Preview
|
|
摘要:
The purpose of this study was to evaluate the efficacy and toxicity of an induction chemotherapy schedule followed by high-dose radiotherapy and concurrent chemotherapy for locally advanced squamous cell carcinomas of the upper and midthoracic esophagus. Patients were treated with three courses of fluorouracil, leucovorin, etoposide, and cisplatin-containing induction chemotherapy followed by high-dose external beam radiotherapy to 65 Gy in 6 weeks for T4 and obstructing T3 tumors. Transversable T3 tumors received 60 Gy in 6 weeks by external radiotherapy, followed by two high-dose-rate esophageal brachytherapy fractions of 4 Gy in 5-mm tissue depth. Concurrent to radiotherapy, cisplatin and etoposide were given. Long-term survival of 22 patients was 41% and 31% at 2 and 3 years, respectively, with a median follow-up of 39 months. The probability of locoregional tumor recurrence was 60% at 3 years for all patients and 30% for those with a partial or complete response to induction chemotherapy. Acute toxicity of this schedule was moderate. Long-term survivors had a good swallowing function. This schedule offers a considerable chance of long-term survival for patients with locally advanced squamous cell carcinomas of the upper and midthoracic esophagus. Local in-field recurrences are the main risk after definitive radiochemotherapy. Dose escalation of radiotherapy is possible because of the observed low late toxicity.
ISSN:0277-3732
出版商:OVID
年代:2000
数据来源: OVID
|
5. |
Primary Granulocytic Sarcoma of the Ovary |
|
American Journal of Clinical Oncology: Cancer Clinical Trials,
Volume 23,
Issue 3,
2000,
Page 239-240
G. Sreejith,
V. Gangadharan,
K. Elizabath,
S. Preetha,
K. Chithrathara,
Preview
|
|
摘要:
Granulocytic sarcomas are rare extramedullary tumors of malignant myeloid precursor cells. Exceedingly rare in childhood, it commonly involves skin, lymph nodes, bone, and the spine. Ovarian involvement is rare. It can arise de novo, precede the development of acute nonlymphocytic leukemia, or be the sole manifestation of relapse. We describe a 26-year-old woman with granulocytic sarcoma of the ovary without any hematologic disorder.
ISSN:0277-3732
出版商:OVID
年代:2000
数据来源: OVID
|
6. |
Cytokeratin Fragment 19 and Squamous Cell Carcinoma Antigen for Early Prediction of Recurrence of Squamous Cell Lung Carcinoma |
|
American Journal of Clinical Oncology: Cancer Clinical Trials,
Volume 23,
Issue 3,
2000,
Page 241-243
Shung-Shung Sun,
Jih-Fang Hsieh,
Shih-Chuan Tsai,
Yung-Jen Ho,
Jong-Kang Lee,
Chia-Hung Kao,
Preview
|
|
摘要:
Sixty patients with squamous cell carcinoma (SCC) of the lung, including 25 cases with recurrence and 35 cases without recurrence 1 year after operation, were enrolled in this study. The serial serum levels of cytokeratin fragment 19 (CYFRA 21-1) and SCC antigen were measured before operation and 1 week, 1 month, 3 months, 6 months, 9 months, and 12 months after operation for early detection of recurrence. The results revealed that 1) mean serum values of CYFRA 21-1 were significantly higher at early and any times after operation in 25 patients with recurrent SCC when compared with 35 patients without recurrent SCC; and 2) mean serum values of SCC antigen were significantly higher until 9 and 12 months after operation, in 25 patients with recurrent SCC when compared with 35 patients without recurrent SCC. We conclude that CYFRA 21-1 is a better marker than SCC antigen for early prediction of SCC recurrence in the lung.
ISSN:0277-3732
出版商:OVID
年代:2000
数据来源: OVID
|
7. |
Treatment of Malignant Ovarian Germ Cell Tumors With Preservation of FertilityReproductive Performance After Persistent Remission |
|
American Journal of Clinical Oncology: Cancer Clinical Trials,
Volume 23,
Issue 3,
2000,
Page 244-248
Koji Kanazawa,
Takaaki Suzuki,
Kaoru Sakumoto,
Preview
|
|
摘要:
To describe our experience with malignant ovarian germ cell tumors with special reference to reproductive performance after remission, medical records of 31 patients were reviewed. The mean age at diagnosis was 18.6 years. Tumor by stage was I in 16 cases, II in 5, III in 5, IV in 3, and recurrence in 2. Histology was dysgerminoma in 7 cases, yolk sac tumor in 10, immature teratoma in 7, choriocarcinoma in 1, and mixed-type tumor in 6. Conservative surgery for fertility preservation was performed in 21 cases. Postoperative chemotherapy was given to all cases except two with stage Ia dysgerminoma. Of 31 cases, 4 including one fertility-preserved case died of disease. The other 27 cases including 20 fertility-preserved cases were successfully treated. Twenty-five cases (92.6%) have been followed longer than 60 months and 13 cases (48.1%) longer than 120 months. By the last follow-up, 8 of the 20 fertility-preserved cases delivered a total of 9 normal babies. Of the remaining 12 nonpregnant cases, 3 married, 9 have had regular menses, and 3 have had menstrual problems. Two of the latter three cases have been in hypergonadotropic anovulatory cycles. One patient has been diagnosed with tubal infertility caused by peritubal adhesion. Thus, management of the disease with fertility preservation is safe and the majority of patients can attain or retain normal ovarian function and reproductive potential.
ISSN:0277-3732
出版商:OVID
年代:2000
数据来源: OVID
|
8. |
Standard Off-Cord Lung Oblique Fields Do Not Include the Entire MediastinumA Computed Tomography Simulator Study |
|
American Journal of Clinical Oncology: Cancer Clinical Trials,
Volume 23,
Issue 3,
2000,
Page 249-252
Steven DiBiase,
Maria Werner-Wasik,
Raymond Croce,
John Sweet,
Walter Curran,
Preview
|
|
摘要:
The routinely recommended target volume for off-cord lung oblique fields in the treatment of postoperative bronchogenic carcinoma includes the entire mediastinum, as defined by coverage of the contralateral mainstem bronchus and subcarinal space. However, this may be difficult to accomplish with the field angles of 20° to 40°, recommended in the recently completed Intergroup Trial (Radiation Therapy Oncology Group 91-05). This project was undertaken to define the oblique angle necessary to encompass the entire mediastinum as determined by computerized tomography simulator verification. Axial computerized tomography simulation images of 25 patients with non–small-cell lung cancer were used in this study. Ten patients had prior lobectomy or pneumonectomy as part of their management. The contralateral mainstem bronchus, subcarinal space (SS), and the spinal cord were each contoured as separate volumes. The length of the contralateral mainstem bronchus was defined as extending from the carina to the bifurcation of the lobar bronchi. The subcarinal space was defined as a triangular space (in a coronal plane) with the carina at the apex, the mainstem bronchi superiorly, and a horizontal line 5 cm below the carina as the base of the triangle. The minimal angle to encompass the contralateral mainstem bronchus and subcarinal space, and to exclude the spinal cord was determined for each patient. The contoured volumes did not have additional margin added. The position of the carina was scored as “midline” if located in the midsagittal plane, or “off-midline” if deviated to either side from midline. Midline deviation was determined at the level of the carina to evaluate possible anatomical distortion relating to the tumor or prior surgery, and its effect on the minimal angle was assessed. The median minimal angle measured was 45° (range: 28–65°) for the entire group, and in 64% of those evaluated, this oblique angle was significantly greater than the 40° recommended in Radiation Therapy Oncology Group guidelines (p= 0.017). In patients without midline deviation (n = 17), the median minimal angle was 45° (range: 28–60°), and in patients with midline deviation (n = 8), it was determined to be 44° (range: 27–65°), with no statistical difference noted between the two groups (p= NS). Although midline deviation was present in 4 of 10 patients previously resected, the above relationship remained unchanged. Based on computerized tomography simulation verification, off-cord oblique field angles of 20° to 40° do not adequately cover the entire mediastinum in most patients. To adequately encompass the entire mediastinum as defined in the Intergroup Trial (Radiation Therapy Oncology Group 91-05) with off-cord oblique fields, treatment angles greater than 40° are necessary. Whether the potential increase in lung volume exposed to radiation from these larger angles results in a poorer therapeutic ratio requires further investigation.
ISSN:0277-3732
出版商:OVID
年代:2000
数据来源: OVID
|
9. |
Control of Cisplatin-Induced Emesis With Intravenous Ondansetron Plus Intravenous DexamethasoneA Crossover Study of Triple 8-mg Dose of Ondansetron |
|
American Journal of Clinical Oncology: Cancer Clinical Trials,
Volume 23,
Issue 3,
2000,
Page 253-257
Chuang-Chi Liaw,
Cheng-Hsu Wang,
Hsien-Kun Chang,
Chen-Yi Kao,
Jen-Sheng Huang,
Preview
|
|
摘要:
Two hundred seventy-five patients were enrolled in one of two arms in a crossover fashion. Arm A: three 8-mg doses of ondansetron intravenous (IV) were given at 4-hour intervals plus dexamethasone 20 mg IV from the start of chemotherapy followed by dexamethasone 5 mg IV every 12 hours. Arm B: as in arm A but with three 8-mg doses of ondansetron IV were given at 24-hour intervals substituted for ondansetron IV given at 4-hour intervals. There were 237 patients in arm A and 223 patients in arm B. Complete protection from acute and delayed vomiting/nausea obtained in arm A was 94.5%/90.3% and 71.3%/57.8%, respectively; protection obtained in arm B was 92.7%/91.0% and 71.7%/60.5%, respectively. No differences were observed in control of acute emesis after the addition of dexamethasone to ondansetron, given as either a triple 8-mg dose at 4-hour intervals or a single 8-mg dose. The triple dose of ondansetron given at 24-hour intervals was also not more effective than ondansetron given at 4-hour intervals in preventing delayed emesis when dexamethasone was added. However, the former improved control of delayed nausea on day 2. Adverse events tended to be minor, with constipation and hiccup the most common.
ISSN:0277-3732
出版商:OVID
年代:2000
数据来源: OVID
|
10. |
21-Day Oral Etoposide for Metastatic Breast CancerA Phase II Study and Review of the Literature |
|
American Journal of Clinical Oncology: Cancer Clinical Trials,
Volume 23,
Issue 3,
2000,
Page 258-262
Thomas Saphner,
Edie Weller,
Douglass Tormey,
Kishan Pandya,
Carla Falkson,
James Stewart,
Nicholas Robert,
Preview
|
|
摘要:
Previous studies of etoposide for metastatic breast cancer commonly used bolus regimens given over a short period of time and included heavily pretreated patients. Results were poor. Chronic oral regimens would be expected to be superior to bolus doses based on pharmacologic studies and patients with less previous chemotherapy would be expected to have higher response rates. We studied the efficacy of oral etoposide at a dose of 50 mg/m2/day for 21 days of a 28-day cycle in good-risk patients with metastatic breast cancer. Healthy patients (Eastern Cooperative Oncology Group performance status 0, 1, or 2) who had not received chemotherapy for at least 1 year before study entry were selected for therapy. Thirty-four patients were entered; three patients were ineligible and one was cancelled. Thirty patients were available for analysis of response. One complete response and eight partial responses were documented (response rate, 30%; 95% confidence interval, 15–49%). A higher response rate was observed in those patients who never received chemotherapy compared with those who had received prior chemotherapy (57 vs. 6%,p= 0.004). There were two treatment-related deaths, both owing to myelosuppression and infection. We found long-term administration of oral etoposide to have a reasonable response rate for metastatic breast cancer (30%). Our response rate was comparable to those of other published studies of long-term oral etoposide regimens for metastatic breast cancer. Response rates in single-arm studies have generally been higher for long-term oral regimens than those for bolus regimens. We also found the regimen to be significantly toxic, an observation that may be underemphasized in the earlier literature.
ISSN:0277-3732
出版商:OVID
年代:2000
数据来源: OVID
|
|